Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984535442> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2984535442 endingPage "5117" @default.
- W2984535442 startingPage "5117" @default.
- W2984535442 abstract "Method: A query was generated to retrieve all cases treated with CPX-351 at Beaumont Health System. SPSS software was used to perform descriptive statistics. Results: We found 11 cases treated with CPX-351 from 2017 to 2019. Six patients were male and 5 females. The median age at diagnosis was 67. Eight patients were Caucasian, two African American and one Asian. The median body mass index (BMI) was 27.1 and median body surface area (BSA) was ! treated with CPX-351 after a diagnosis of AML-MRC and 4 patients (36.3%) with t-AML. The median hospital stay was 35 days. The median units of red blood cells transfusion during hospital stay were 9 units and the median number of transfused platelet units was 6. Only 2 patients (18.1%) achieved complete response (CR) and 2 patients (18.1%) achieved complete response with incomplete blood count recovery (CRi). Three patients developed allergic reactions presented as a rash, 2 patients had significant bleeding and all 11 patients developed neutropenic fever. Three patients died during induction therapy and 2 patients underwent allogeneic hematopoietic stem cell transplant. Six patients (54.5%) died within 90 days of starting induction therapy. Conclusion: t-AML and AML-MRC remain to have dismal prognosis. Our study highlights the high early mortality rate associated with induction therapy with CPX-351. The most common cause of death was refractory or relapsed leukemia. The high incidence of neutropenic fever was also more prevalent to what has been reported. Disclosures No relevant conflicts of interest to declare." @default.
- W2984535442 created "2019-11-22" @default.
- W2984535442 creator A5048242422 @default.
- W2984535442 creator A5055019932 @default.
- W2984535442 creator A5057433035 @default.
- W2984535442 creator A5066085448 @default.
- W2984535442 creator A5087442674 @default.
- W2984535442 date "2019-11-13" @default.
- W2984535442 modified "2023-09-27" @default.
- W2984535442 title "Outcome of Patients with Newly-Diagnosed Therapy-Related AML (t-AML) and AML with Myelodysplasia-Related Changes (AML-MRC) Treated with Liposomal Daunorubicin and Cytarabine (CPX-351) at an Academic Community-Based Health System" @default.
- W2984535442 doi "https://doi.org/10.1182/blood-2019-130776" @default.
- W2984535442 hasPublicationYear "2019" @default.
- W2984535442 type Work @default.
- W2984535442 sameAs 2984535442 @default.
- W2984535442 citedByCount "0" @default.
- W2984535442 crossrefType "journal-article" @default.
- W2984535442 hasAuthorship W2984535442A5048242422 @default.
- W2984535442 hasAuthorship W2984535442A5055019932 @default.
- W2984535442 hasAuthorship W2984535442A5057433035 @default.
- W2984535442 hasAuthorship W2984535442A5066085448 @default.
- W2984535442 hasAuthorship W2984535442A5087442674 @default.
- W2984535442 hasBestOaLocation W29845354421 @default.
- W2984535442 hasConcept C126322002 @default.
- W2984535442 hasConcept C141071460 @default.
- W2984535442 hasConcept C187212893 @default.
- W2984535442 hasConcept C2777408962 @default.
- W2984535442 hasConcept C2778041864 @default.
- W2984535442 hasConcept C2778461978 @default.
- W2984535442 hasConcept C2911091166 @default.
- W2984535442 hasConcept C71924100 @default.
- W2984535442 hasConcept C88879693 @default.
- W2984535442 hasConceptScore W2984535442C126322002 @default.
- W2984535442 hasConceptScore W2984535442C141071460 @default.
- W2984535442 hasConceptScore W2984535442C187212893 @default.
- W2984535442 hasConceptScore W2984535442C2777408962 @default.
- W2984535442 hasConceptScore W2984535442C2778041864 @default.
- W2984535442 hasConceptScore W2984535442C2778461978 @default.
- W2984535442 hasConceptScore W2984535442C2911091166 @default.
- W2984535442 hasConceptScore W2984535442C71924100 @default.
- W2984535442 hasConceptScore W2984535442C88879693 @default.
- W2984535442 hasIssue "Supplement_1" @default.
- W2984535442 hasLocation W29845354421 @default.
- W2984535442 hasOpenAccess W2984535442 @default.
- W2984535442 hasPrimaryLocation W29845354421 @default.
- W2984535442 hasRelatedWork W1473782864 @default.
- W2984535442 hasRelatedWork W2004368639 @default.
- W2984535442 hasRelatedWork W2009733242 @default.
- W2984535442 hasRelatedWork W2161996216 @default.
- W2984535442 hasRelatedWork W2357142827 @default.
- W2984535442 hasRelatedWork W2543872697 @default.
- W2984535442 hasRelatedWork W2614629048 @default.
- W2984535442 hasRelatedWork W2794187412 @default.
- W2984535442 hasRelatedWork W3006459057 @default.
- W2984535442 hasRelatedWork W3031956895 @default.
- W2984535442 hasVolume "134" @default.
- W2984535442 isParatext "false" @default.
- W2984535442 isRetracted "false" @default.
- W2984535442 magId "2984535442" @default.
- W2984535442 workType "article" @default.